Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-05 4:10 pm Sale | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,670,930 5.9% | -94,600 (-3.42%) | View |
| 2024-03-19 11:20 am Sale | 13G | TRACON PHARMACEUTICALS INC TCON | aaronson wayne | 716,925 2.3% | -1,061,528 (-59.69%) | View |
| 2024-02-14 4:31 pm Sale | 13G | TRACON PHARMACEUTICALS INC TCON | Lincoln Park Capital Fund LLC | 116,821 0.375% | -2,253,000 (-95.07%) | View |
| 2024-02-09 4:05 pm Sale | 13D | TRACON PHARMACEUTICALS INC TCON | Opaleye Management Inc. | 0 0% | -2,518,371 (Position Closed) | View |
| 2023-06-02 4:46 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Lincoln Park Capital Fund LLC | 2,369,821 8.98% | 2,369,821 (New Position) | View |
| 2023-02-14 12:57 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,765,530 12.5% | 74,420 (+2.77%) | View |
| 2023-02-10 2:07 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | aaronson wayne | 1,778,453 8.17% | 312,335 (+21.30%) | View |
| 2022-04-29 5:17 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | aaronson wayne | 1,466,118 7% | 1,466,118 (New Position) | View |
| 2022-02-14 4:37 pm Sale | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,691,110 13.8% | -25,730 (-0.95%) | View |
| 2022-01-27 4:03 pm Unchanged | 13G | TRACON PHARMACEUTICALS INC TCON | Linden Capital L.P. | 921,603 4.6% | 0 (Unchanged) | View |
| 2021-03-10 9:40 pm Sale | 13D | TRACON PHARMACEUTICALS INC TCON | New Enterprise Associates 14 L.P. | 0 0% | -3,568,753 (Position Closed) | View |
| 2021-02-16 3:09 pm Sale | 13G | TRACON PHARMACEUTICALS INC TCON | 683 Capital Management LLC | 198,893 1.3% | -60,000 (-23.18%) | View |
| 2021-02-16 08:33 am Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,716,840 17.8% | 554,291 (+25.63%) | View |
| 2021-02-12 5:20 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Opaleye Management Inc. | 2,518,371 17.04% | 2,518,371 (New Position) | View |
| 2021-02-09 3:17 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Linden Capital L.P. | 921,603 6% | 921,603 (New Position) | View |
| 2020-09-14 5:00 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,162,549 16.4% | 2,162,549 (New Position) | View |
| 2020-08-31 9:40 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Opaleye Management Inc. | 1,718,346 13.03% | 1,718,346 (New Position) | View |
| 2020-02-13 8:30 pm Sale | 13D | TRACON PHARMACEUTICALS INC TCON | Puissance Cross-Border Opportunities V LLC | 76,048 2.42% | -4,525,720 (-98.35%) | View |
| 2020-02-13 10:02 am Sale | 13G | TRACON PHARMACEUTICALS INC TCON | 683 Capital Management LLC | 258,893 8.3% | -2,722,357 (-91.32%) | View |
| 2020-01-14 4:01 pm Sale | 13G | TRACON PHARMACEUTICALS INC TCON | Linden Capital L.P. | 296,380 9.9% | -2,687,765 (-90.07%) | View |